In 61 adults with type 2 diabetes, a 6-week GIP infusion did not significantly lower 14-day mean CGM glucose versus placebo, alone (+0·80 mmol/L, p=0·13) or added to semaglutide (+0·05 mmol/L, p=1·00). Dropouts limit conclusions on GIP alone.
RCTn = 61
Helsted et al. Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial